Oct 28, 2025
Alkaloid – 22 Years Participating in the Leading Global Pharmaceutical Event, CPhI
A diverse team of 35 professionals from across Alkaloid’s organizational sectors is representing the company at this year’s 36th edition of CPhI, with more than 400 business meetings scheduled over three intensive days with existing partners, suppliers, and potential new collaborators.
This year marks Alkaloid’s 22nd participation at CPhI (Convention of Pharmaceutical Ingredients) – the foremost global gathering for the pharmaceutical industry. Held under the theme “At the Heart of Pharma,” the event takes place from October 28 to 30 in Frankfurt, Germany. Once again, Alkaloid’s team is presenting a modern, visually engaging stand that reflects the company’s guiding principle — Health above all!
“For Alkaloid, CPhI is a vital global platform for tracking the latest scientific and technological breakthroughs in the pharmaceutical sector. We recognized the potential of this global gathering early in the 2000s — both as an opportunity to build valuable business connections and partnerships, and to stay aligned with key transformations and innovations within the generic pharmaceutical industry. CPhI offers us direct exposure to emerging trends and technologies — from artificial intelligence and sustainable manufacturing practices to new molecules, formulations, and solutions that optimize the global supply chain. It also provides a unique opportunity to engage with existing and potential partners — manufacturers, suppliers, regulatory consultants, and research centers— fostering new partnerships and synergies,” noted Zhivko Mukaetov, Chief Executive Officer and MB President of Alkaloid.
As the world’s leading networking platform for pharmaceutical professionals, CPhI Frankfurt 2025 gathers over 62,000 visitors and 2,400 exhibitors from around the globe. Over the past three and a half decades, CPhI has grown into the largest international pharmaceutical community, connecting hundreds of thousands of experts and companies committed to driving innovation and progress across the dynamic global pharmaceutical supply chain.